Britt Hanson

Roosevelt Dr, Headington
Oxford, ENG OX37TY, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Targeted BDNF upregulation via upstream open reading frame disruption.

Targeted BDNF upregulation via upstream open reading frame disruption.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: April 17, 2025

uORF-targeting steric block antisense oligonucleotides do not reproducibly increase RNASEH1 expression.

uORF-targeting steric block antisense oligonucleotides do not reproducibly increase RNASEH1 expression.

Journal: Molecular therapy. Nucleic acids

Published: August 03, 2024

Expanding Access to Noninvasive Prenatal Diagnosis for Monogenic Conditions to Consanguineous Families.

Expanding Access to Noninvasive Prenatal Diagnosis for Monogenic Conditions to Consanguineous Families.

Journal: Clinical chemistry

Published: November 02, 2023

Non-invasive prenatal diagnosis (NIPD): current and emerging technologies.

Non-invasive prenatal diagnosis (NIPD): current and emerging technologies.

Journal: Extracellular vesicles and circulating nucleic acids

Published: December 23, 2022

EV-mediated promotion of myogenic differentiation is dependent on dose, collection medium, and isolation method.

EV-mediated promotion of myogenic differentiation is dependent on dose, collection medium, and isolation method.

Journal: Molecular therapy. Nucleic acids

Published: December 11, 2022

Non-invasive prenatal diagnosis (NIPD): how analysis of cell-free DNA in maternal plasma has changed prenatal diagnosis for monogenic disorders.

Non-invasive prenatal diagnosis (NIPD): how analysis of cell-free DNA in maternal plasma has changed prenatal diagnosis for monogenic disorders.

Journal: Clinical science (London, England : 1979)

Published: September 01, 2022

Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD.

Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD.

Journal: Molecular therapy. Nucleic acids

Published: May 12, 2022

Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing.

Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing.

Journal: RNA biology

Published: January 21, 2021

Mutation-independent Proteomic Signatures of Pathological Progression in Murine Models of Duchenne Muscular Dystrophy.

Mutation-independent Proteomic Signatures of Pathological Progression in Murine Models of Duchenne Muscular Dystrophy.

Journal: Molecular & cellular proteomics : MCP

Published: September 09, 2020

Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.

Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: September 01, 2020

Extracellular microRNAs exhibit sequence-dependent stability and cellular release kinetics.

Extracellular microRNAs exhibit sequence-dependent stability and cellular release kinetics.

Journal: RNA biology

Published: March 07, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026